Physician profile
Sam Afshar
NPI 1992913933
$3,709.98
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,301 · 2020: $264 · 2021: $2,043 · 2023: $16.18 · 2024: $86.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $102.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,414.17 | 2021 | |
| Biotronik INC. | $320.77 | 2019 | |
| Asahi Intecc USA, INC. | $317.16 | 2020-2021 | |
| Medtronic, INC. | $311.39 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $176.90 | 2019 | |
| Acutus Medical, INC. | $166.97 | 2019 | |
| Amgen INC. | $159.83 | 2019-2020 | |
| Medtronic Vascular, INC. | $145.08 | 2019 | |
| Cardiovascular Systems INC. | $144.78 | 2021 | |
| Abbott Laboratories | $93.34 | 2019-2023 | 2nd Gen Centrimag Primary Console |
| Janssen Pharmaceuticals, INC | $86.31 | 2019 | |
| Boston Scientific Corporation | $62.37 | 2019-2021 | |
| Acist Medical Systems, INC. | $62.19 | 2024 | |
| Novartis Pharmaceuticals Corporation | $53.92 | 2019 | |
| Irhythm Technologies, INC. | $52.29 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $35.66 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $32.00 | 2019 | |
| Cardiva Medical, INC. | $24.13 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Regeneron Healthcare Solutions, INC. | $14.26 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.90 | 2019 | |
| Medicomp INC | $12.07 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Afshar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.